This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Antag Therapeutics Aps. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Bjørn Behrens Sivertsen
Introduction
Bjørn Behrens Sivertsen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of peptide analogues, particularly in the development of glucose-dependent insulinotropic peptide (GIP) derivatives. His work focuses on enhancing pharmacological properties through innovative modifications.
Latest Patents
Sivertsen holds 2 patents related to modified GIP peptide analogues. These patents disclose peptide analogues derived from GIP that act as antagonists of the GIP receptor. The modifications include one or more amino acid substitutions and fatty acid conjugation, which improve both antagonistic activity and pharmacokinetic profiles.
Career Highlights
Bjørn Behrens Sivertsen is associated with Antag Therapeutics Aps, where he applies his expertise in peptide research. His innovative approach has positioned him as a key figure in the development of therapeutic agents targeting metabolic disorders.
Collaborations
Sivertsen collaborates with talented individuals such as Alexander Hovard Sparre-ulrich and Ditte Riber, contributing to a dynamic research environment that fosters innovation.
Conclusion
Bjørn Behrens Sivertsen's work in peptide analogues exemplifies the intersection of innovation and therapeutic development. His contributions are paving the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile